Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
223.83B | 214.31B | 175.47B | 147.47B | 152.82B | 204.63B | Gross Profit |
25.11B | 23.68B | 4.24B | 4.61B | 4.50B | 22.69B | EBIT |
2.56B | 2.25B | -14.79B | -12.19B | -12.97B | 4.03B | EBITDA |
28.56B | 12.25B | -2.16B | -9.27B | -3.99B | 14.08B | Net Income Common Stockholders |
-5.86B | -313.00M | -13.66B | -19.03B | -17.08B | -2.02B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
10.85B | 24.12B | 32.87B | 27.94B | 21.32B | 22.70B | Total Assets |
126.15B | 142.04B | 148.82B | 142.93B | 145.54B | 150.69B | Total Debt |
26.73B | 74.32B | 79.69B | 71.12B | 60.39B | 47.13B | Net Debt |
15.89B | 52.42B | 46.82B | 43.18B | 39.07B | 24.43B | Total Liabilities |
74.08B | 119.61B | 127.51B | 111.13B | 98.10B | 85.70B | Stockholders Equity |
45.98B | 12.36B | 11.48B | 22.33B | 38.66B | 55.99B |
Cash Flow | Free Cash Flow | ||||
3.49B | -4.26B | -5.39B | -3.71B | -14.29B | -6.21B | Operating Cash Flow |
3.49B | -547.00M | -1.90B | 2.07B | -4.22B | 6.88B | Investing Cash Flow |
0.00 | 871.00M | 2.74B | -3.60B | -7.54B | -11.95B | Financing Cash Flow |
0.00 | -10.74B | 2.34B | 6.24B | 10.27B | 8.80B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $2.00T | 5.02 | 15.47% | 3.95% | 6.27% | 19.66% | |
76 Outperform | €150.64B | 10.66 | 6.70% | 3.75% | -1.41% | -37.77% | |
74 Outperform | $3.53T | 8.35 | 15.02% | 2.07% | 14.46% | 62.35% | |
71 Outperform | $1.11T | 13.69 | 7.19% | 4.11% | 4.48% | -51.81% | |
70 Outperform | $605.09B | 14.46 | 4.11% | 3.60% | -0.06% | -39.78% | |
61 Neutral | $6.93B | 11.84 | 2.89% | 3.91% | 2.59% | -21.68% | |
39 Underperform | ¥3.17B | ― | ― | 33.86% | 69.12% |